Algert Global LLC Liva Nova PLC Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Liva Nova PLC stock. As of the latest transaction made, Algert Global LLC holds 105,017 shares of LIVN stock, worth $4.91 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

105,017

Previous 58,009 81.04%

Holding current value

$4.91 Million

Previous $3.18 Million 73.52%

% of portfolio

0.15%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$43.38 - $54.59 $2.04 Million - $2.57 Million	47,008 Added 81.04%	105,017 $5.52 Million
Q2 2024 Aug 14, 2024	BUY	$51.76 - $64.15 $3,002 - $3,720	58 Added 0.1%	58,009 $3.18 Million
Q1 2024 May 14, 2024	BUY	$48.6 - $57.12 $623,489 - $732,792	12,829 Added 28.43%	57,951 $3.24 Million
Q4 2023 Feb 14, 2024	BUY	$43.45 - $53.66 $129,915 - $160,443	2,990 Added 7.1%	45,122 $2.34 Million
Q3 2023 Nov 13, 2023	SELL	$50.12 - $58.87 $2.77 Million - $3.26 Million	-55,311 Reduced 56.76%	42,132 $2.23 Million
Q2 2023 Aug 14, 2023	BUY	$42.28 - $51.43 $950,581 - $1.16 Million	22,483 Added 29.99%	97,443 $5.01 Million
Q1 2023 May 12, 2023	BUY	$40.84 - $58.14 $3.06 Million - $4.36 Million	74,960 New	74,960 $3.27 Million
Q2 2022 Aug 15, 2022	SELL	$57.25 - $86.63 $254,762 - $385,503	-4,450 Reduced 42.2%	6,094 $381,000
Q1 2022 May 16, 2022	BUY	$71.02 - $86.99 $748,834 - $917,222	10,544 New	10,544 $863,000
Q4 2020 Feb 12, 2021	SELL	$46.01 - $68.74 $255,631 - $381,919	-5,556 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$41.91 - $57.81 $102,553 - $141,461	-2,447 Reduced 30.58%	5,556 $251,000
Q2 2020 Aug 12, 2020	BUY	$39.87 - $56.9 $319,079 - $455,370	8,003 New	8,003 $385,000

Others Institutions Holding LIVN

# of Institutions

261

Shares Held

52.9M

Call Options Held

316K

Put Options Held

127K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.5B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Liva Nova PLC Transaction History